Company / Cash per Share
LENZ Therapeutics, Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.91
FY2025
5-year range
$0.87 / $17.94
FY2021-FY2025
Trend
-3.4%
vs FY2024
Sector context
#151 of 205
Health Care
What the data says
At $0.91, LENZ Therapeutics, Inc.'s cash per share ranks #151 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 6 years, ranging from $0.87 in FY2022 to $17.94 in FY2023.
Based on SEC 10-K filings.
0.91 in FY2025 with a 5-year CAGR of -36.2%.
Declined from $17.94 to $0.91 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- -36.2%
- 10-Year CAGR
- -
Sector benchmark
#151 of 205 in Health CareTop 74% of 205This company $0.91 Sector average $72.93
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 3.4% year-over-year.
- Ranks #151 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.91 | -3.4% |
| FY2024 | $0.95 | -94.7% |
| FY2023 | $17.94 | +1962.1% |
| FY2022 | $0.87 | -93.3% |
| FY2021 | $13.04 | +50.5% |
| FY2020 | $8.66 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026